- Home
- CRMD vs VINP Comparison
CRMD vs VINP Comparison
Compare CRMD & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- VINP
- Stock Information
- Founded
- CRMD 2006
- VINP 2009
- Country
- CRMD United States
- VINP Brazil
- Employees
- CRMD N/A
- VINP N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- VINP Investment Managers
- Sector
- CRMD Health Care
- VINP Finance
- Exchange
- CRMD Nasdaq
- VINP Nasdaq
- Market Cap
- CRMD 626.8M
- VINP 694.1M
- IPO Year
- CRMD 2010
- VINP 2021
- Fundamental
- Price
- CRMD $10.33
- VINP $10.21
- Analyst Decision
- CRMD Strong Buy
- VINP Strong Buy
- Analyst Count
- CRMD 5
- VINP 2
- Target Price
- CRMD $15.20
- VINP $14.50
- AVG Volume (30 Days)
- CRMD 1.6M
- VINP 60.7K
- Earning Date
- CRMD 10-30-2024
- VINP 11-07-2024
- Dividend Yield
- CRMD N/A
- VINP 6.67%
- EPS Growth
- CRMD N/A
- VINP N/A
- EPS
- CRMD N/A
- VINP 0.60
- Revenue
- CRMD $12,262,234.00
- VINP $88,217,697.00
- Revenue This Year
- CRMD N/A
- VINP $7.69
- Revenue Next Year
- CRMD $277.75
- VINP $11.35
- P/E Ratio
- CRMD N/A
- VINP $17.03
- Revenue Growth
- CRMD 41184.20
- VINP 9.03
- 52 Week Low
- CRMD $2.89
- VINP $9.01
- 52 Week High
- CRMD $13.85
- VINP $11.85
- Technical
- Relative Strength Index (RSI)
- CRMD 47.20
- VINP 46.39
- Support Level
- CRMD $10.16
- VINP $10.51
- Resistance Level
- CRMD $11.41
- VINP $10.95
- Average True Range (ATR)
- CRMD 0.73
- VINP 0.27
- MACD
- CRMD -0.18
- VINP -0.05
- Stochastic Oscillator
- CRMD 31.00
- VINP 29.73
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.
About VINP Vinci Partners Investments Ltd.
Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Market; Liquid Strategies; Investment Products and solutions; Financial Advisory; and Retirement Services. The company's majority of its revenue comes from the Private Market segment which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.